Creatinine
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Creatinine | |
|---|---|
| |
| |
| IUPAC name | 2-amino-1-methyl-5H-imidazol-4-one |
| Identifiers | |
| CAS number | |
| PubChem | |
| MeSH | |
| SMILES | CN1CC(=O)N=C1N |
| Properties | |
| Molecular formula | C4H7N3O |
| Molar mass | 113.118 |
| Appearance | Solid |
| Density | 1.09 g/cm3 |
| Melting point |
300 °C |
| Hazards | |
| NFPA 704 |
|
| S-phrases | S24/25 |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references | |
|
WikiDoc Resources for Creatinine | |
|
Articles | |
|---|---|
|
Most recent articles on Creatinine | |
|
Media | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Creatinine at Clinical Trials.gov Clinical Trials on Creatinine at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Creatinine
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Creatinine Discussion groups on Creatinine Patient Handouts on Creatinine Directions to Hospitals Treating Creatinine Risk calculators and risk factors for Creatinine
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Creatinine | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Creatinine is a break-down product of creatine phosphate in muscle, and is usually produced at a fairly constant rate by the body (depending on muscle mass).
Physiology
Creatinine is mainly filtered by the kidney, though a small amount is actively secreted. There is little-to-no tubular reabsorption of creatinine. If the filtering of the kidney is deficient, blood levels rise. As a result, creatinine levels in blood and urine may be used to calculate creatinine clearance (ClCr), which reflects the glomerular filtration rate (GFR). The GFR is clinically important because it is a measurement of renal function. However, in cases of severe renal dysfunction, the creatinine clearance rate will be overestimated because the active secretion of creatinine will account for a larger fraction of the total creatinine cleared.
A more complete estimation of renal function can be made when interpreting the blood (plasma) concentration of creatinine along with that of urea. In the USA, urea concentration is given as blood urea nitrogen (BUN), in mg/dL. In other countries, including those of Europe, urea concentration is measured and quoted in mmol/L.
The ratio of urea to creatinine can indicate other problems besides those intrinsic to the kidney. For example, a urea level raised out of proportion to the creatinine may indicate a pre-renal problem such as dehydration.
Men tend to have higher levels of creatinine because they have more skeletal muscle than women. Vegetarians tend to have lower creatinine levels, because vegetables contain no creatinine.
Diagnostic use
Measuring serum creatinine is a simple test and it is the most commonly used indicator of renal function. A rise in blood creatinine levels is observed only with marked damage to functioning nephrons. Therefore, this test is not suitable for detecting early stage kidney disease. A better estimation of kidney function is given by the creatinine clearance test. Creatinine clearance can be accurately calculated using serum creatinine concentration and some or all of the following variables: sex, age, weight, and race as suggested by the American Diabetes Association without a 24 hour urine collection.[1] Some laboratories will calculate the ClCr if written on the pathology request form; and, the necessary age, sex, and weight are included in the patient information.
Interpretation
In the United States, creatinine is typically reported in mg/dL, while in Canada and Europe μmol/litre may be used. 1 mg/dL of creatinine is 88.4 μmol/l.
The typical reference ranges are 0.5 to 1.0 mg/dL (about 45-90 μmol/l) for women and 0.7 to 1.2 mg/dL (60-110 μmol/l) for men. While a baseline serum creatinine of 2.0 mg/dL (150 μmol/l) may indicate normal kidney function in a male body builder, a serum creatinine of 0.7 mg/dL (60 μmol/l) can indicate significant renal disease in a frail old woman.
More important than absolute creatinine level is the trend of serum creatinine levels over time.
Creatinine levels may increase when ACE inhibitors (ACEI) or angiotensin-II receptor blockers (ARBs) are used in the treatment of chronic heart failure (CHF). Using both ACEI & ARB concomitantly will increase creatinine levels to a greater degree than either of the two drugs would individually. An increase of <30% is to be expected with ACEI or ARB use.
CT Scans
The creatinine level is usually measured before performing a contrast-enhanced Computed tomography (CT) scan. In a small proportion of patients the administration of iodine based contrast can cause kidney damage. This may be more likely or severe in patients with an elevated baseline serum creatinine level and, again, in rare cases may require temporary or permanent dialysis. The risk can be reduced somewhat in higher-risk patients by choosing a low-osmolality contrast medium.
See also
- Cystatin C - novel marker of kidney function.
- Creatinine clearance
References
it:Creatinina he:קריאטינין nl:Kreatinine no:Kreatininsv:Kreatinin
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
